MedTrace Logo

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

NCT00476723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2010-06-07

No results posted yet for this study

Summary

The trial will randomise HIV/HBV co-infected individuals to different HBV-active antiretroviral therapy treatment regimens.

Conditions

  • HIV
  • Hepatitis-B

Sponsors & Collaborators

  • Kirby Institute

    collaborator OTHER_GOV

  • Ministry of Health, Thailand

    collaborator OTHER_GOV

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Kiat Ruxrungtham, MD, MSc · HIV-NAT, The Thai Red Cross AIDS Research Centre

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00476723 on ClinicalTrials.gov